HOLYN KANAKE




THE AI REVOLUTION

We’re in the midst of the biggest technonological revolution since the printing press and nothing matters more than how we craft the policy that guides and governs how it will impact society. In particular:

> Scientific R&D 
> Clinical & care delivery 
> Media creation & storytelling
> Education & workforce
> and much more



_____
Let’s chat: hello@holyn.co & twitter
SCIENCE ECOSYSTEM




Initiatives
Genesis Mission

National Security Commission on Emerging Biotechnology (NSCEB)

Biotech Caucus



Divisions> NSF
> HHS (FDA. NIH, ASHF/ARPA‑H)
> DoD (DARPA)
> SBA (SBIR/STTR)



Bills 
(Intro’d)
 > National Biotech Initiative Act 2025
> National Biotech Safety Act
> Foundation for Enabling Biotechnology Innovation Act
> Independence Investment Fund Act 
> Defense Biotechnology Strategy Act
> Biomanufacturing Excellence Act of 2025
> Clinical Trial Modernization Act



RFIs
(open) Accelerating the Adoption and Use of AI Clinical Care // HHS

Foundational Innovation and RAPID Engagement (FIRE) // FDA

Partnerships for Transformational AI Models // DOE



Recent AI Updates
02/26 — FDA rejects review of Moderna flu vaccine application 

02/26 — Ginkgo & OpenAI autonomous lab

02/26 — Isomorphic eclipses AlphaFold 3 in drug design

01/26 — Life Biosciences gets IND clearance for longevity trials


Wins
BIOSECURE Act included in FY 2026 NDAA              








Last Updated 02.11.26
POLICY FOCUS






1. 
AI as defense



Biggest exports used to be culture and drugs research. We’ve fallen behind. We must fix: 

> R&D funding 
> Gov’t contract access
> Direct industry relationship   
> IP in post-agentic world

Health data, onshoring manufacturing, detecting bioweapons



Ginkgo Bioworks & OpenAI GPT-5 autonomous lab in February 2026. 


2. 
Pro-innovation R&D
Increase investment 
Improve coordination and direct relationship to startups






The messy clinical trials data flow by James Ladyman.



3. 
Lean clinical trials


Key challenges: Streamlining clinical trails (issues: recruiting subjects, incentive structures)





© HK 2026